Grid of patient photos with a blue background

Press

The Virta Treatment reverses type 2 diabetes and other chronic metabolic diseases, safely and sustainably, without the risks, costs, or side effects of medications or surgery. Our mission is to reverse type 2 diabetes in 100 million people by 2025.

For press inquiries and interview requests, feel free to contact us at any time at press@virtahealth.com

Virta Brand Assets

Download our press kit for the latest logos, product screenshots and company photos.

As Featured In

Forbes logoFortuneThe New York Times logoNewsweek logoTechCrunch logoLogo: Business Insider
“Virta gives diabetics a cross between a pocket doctor and a guardian angel.”

Newsweek, How Artificial Intelligence Will Cure America's Sick Health Care System

“Over the past two years, the Pequot Nation reduced its total medication spending by half, roughly $3,800 per [Virta] patient”

USA Today, Native American tribes have long struggled with high rates of diabetes, and COVID-19 made the problem even more urgent

“Virta’s virtual clinic can fill a gap between visits, which is important for people who are dealing with their diseases every day and need additional support.”

STAT, 5 burning questions about digital health and chronic disease management

“It's a much more scalable model than seeing people in a doctor's office.”

The New York Times, Tackling Weight Loss and Diabetes With Video Chats

“…Virta Health, is taking a more daring approach, which it hopes will ultimately eliminate the type 2 diabetes altogether.”

CNBC, This woman tattooed the logo of diabetes management start-up Virta Health on her arm to remind her to stick with the program

About Virta

2014

Founded

$360M

Raised through Series E

50

States where Virta is available

Diabetes Trends (US)

34M

People living with type 2 diabetes

86M

People living with prediabetes

$404B

Economic burden of diabetes

Virta's Clinical Trial

60%

Diabetes reversal rate* at 1 year¹

94%

Patients who reduced or eliminated insulin at 1 year¹

$9,565

Estimated savings per patient for the first two years²

Brand Assets

Virta Leadership

Download photos
Neha, Virta patient

Virta Patients & Providers

Download photos

Citations and Footnotes

  1. Hallberg SJ, McKenzie AL, Williams P, et al. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at One Year: An Open Label, Non-Randomized, Controlled Study. Diabetes Ther. 2018. DOI: 10.1007/s13300-018-0373-9. Reversal rate refers to % of patients with HbA1c less than 6.5% who are taking no diabetes-specific medications.
  2. Note: does not include consideration of Virta fees. Source: Virta internal analysis - Economic Impact Model built using Virta clinical results and published estimates of medical & pharmacy costs by A1c level and BMI from Li et. al., The Economic Burden of Obesity by Glycemic Stage in the United States; PharmacoEconomics (2015) 33:735–748.